300 North Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | $294K | Sell |
2,454
-59,951
| -96% | -$7.18M | 1.8% | 31 |
|
|
2015
Q1 | $6.52M | Sell |
62,405
-1,345
| -2% | -$140K | 1.43% | 19 |
|
|
2014
Q4 | $6.18M | Buy |
63,750
+4,474
| +8% | +$434K | 1.42% | 24 |
|
|
2014
Q3 | $4.63M | Buy |
59,276
+34,174
| +136% | +$2.67M | 1.23% | 27 |
|
|
2014
Q2 | $1.59M | Buy |
25,102
+7,180
| +40% | +$454K | 0.39% | 79 |
|
|
2014
Q1 | $1.2M | Buy |
17,922
+14,602
| +440% | +$981K | 0.31% | 79 |
|
|
2013
Q4 | $214K | Hold |
3,320
| – | – | 0.06% | 102 |
|
|
2013
Q3 | $213K | Buy |
+3,320
| New | +$213K | 0.05% | 116 |
|